High expression of EGFR causes enhanced signaling downstream, promoting cell proliferation and inhibiting apoptosis; gefitinib is an EGFR-TKI that binds EGFR reversibly and plays a role in treating various cancers. This evidence concerns the gene EGFR and cancer.